This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

AMRI Wins 2013 CMO Leadership Award In Quality From Life Science Leader Magazine

ALBANY, N.Y., Aug. 15, 2013 /PRNewswire/ --  AMRI (NASDAQ: AMRI), a leading contract research and manufacturing organization, announces receipt of the 2013 CMO Leadership Award for distinction in Quality from Life Science Leader, an industry-focused news publication. The award acknowledges the survey results of more than 10,000 pharmaceutical and biotechnology executives based on research conducted by Nice Insight. The survey covered more than 100 contract manufacturing organizations (CMOs). AMRI was selected as an award winner in the category of quality, which is generally defined "as a business that will treat a customer's project as if it was its own."

The Life Science Leader annual CMO Leadership Awards will be highlighted and detailed in the publication's annual CMO Leadership Awards supplement, published to coincide with the 2013 AAPS Convention in October 2013. Life Science Leader will formally present the 2013 CMO Leadership Awards at a ceremony and industry gathering in New York City on March 12, 2014.

Thomas E. D'Ambra, Ph.D., President and CEO, AMRI, said, "Quality, commitment to purpose and customer satisfaction and service are important AMRI core values that are part of our culture that we live by. To be recognized by our industry peers and customers as a leading CMO in the area of quality is a great honor and testament to the dedication of my colleagues at AMRI to each and every customer. We are grateful that our customers recognize AMRI SMARTSOURCING™ as a high quality global brand, and we will continue to search for ways to improve our offerings and performance."

About AMRI

Albany Molecular Research, Inc. (AMRI) is a global contract research and manufacturing organization offering customers fully integrated drug discovery, development and manufacturing services. For over 21 years, AMRI has demonstrated its adaptability as the pharmaceutical and biotechnology industries have undergone tremendous change in response to multiple challenges. This experience, a track record of success and locations in the United States, Europe and Asia now provides our customers with SMARTSOURCING , a full range of value-added opportunities providing customers with informed decision-making, enhanced efficiency and more successful outcomes at all stages of the pipeline. AMRI has also successfully partnered R&D programs and is actively seeking to out-license its remaining programs for further development. For more information about AMRI, please visit our website at http://www.amriglobal.com or follow us on Twitter ( @amriglobal).

SOURCE AMRI

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 17,757.84 +11.86 0.07%
S&P 500 2,113.52 +4.89 0.23%
NASDAQ 5,150.4390 +21.6540 0.42%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs